Navigation Links
DaVita Launches 'Flu Fighter Program' in Support of National Influenza Week

EL SEGUNDO, Calif., Dec. 10 /PRNewswire-FirstCall/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney failure and disease (CKD), continues to push the Flu Fighters initiative which takes place during the month of December to complement the events of National Influenza Week, Dec. 8 - 14.


The National Influenza Week kicks off this week and is designed to raise awareness of the importance of continuing influenza (flu) vaccination, as well as foster greater use of flu vaccine in December, January, and beyond.

DaVita(R) strives to educate every patient on the benefits of the flu vaccine and hopes to ensure at least 90 percent of patients at every center get vaccinated. Vaccination is one of the most effective interventions available to save lives and prevent hospitalization in dialysis patients. Dialysis patients who already suffer from End Stage Renal Disease are at high risk for the flu, and DaVita hopes this initiative will combat those odds.

Allen R. Nissenson, MD, Chief Medical Officer at DaVita said, "Each year more than 200,000 people are hospitalized for influenza-related complications. Influenza vaccinations are of the highest clinical focus in our company. We want our patients to be as healthy as possible and vaccinations are an opportunity to prevent illness before it starts. It is just one more way to provide for quality patient care and put our patients first."

The flu vaccinations are available at no cost to all DaVita patients and are covered by Medicare. The DaVita Flu Fighters immunization standards are in sync with the Centers for Medicare and Medicaid Services initiative called Healthy People 2010. DaVita expects that more than 90 percent of its patients, as well as direct patient case employees, will be vaccinated to decrease the chances of spreading disease across the dialysis center and to optimize the health of its patients.

DaVita is a registered trademarks of DaVita Inc. All other trademarks are the properties of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,400 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 110,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials, and its community programs, please visit

SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DaVita Treats Thousands of Dialysis Patients in Wake of Hurricane Ike
2. Superior Patient Clinical Outcomes Confirms DaVitas Leadership Position on Quality Dialysis Care
3. Third Annual DaVita Kidney Disease Awareness Walks to Hit 20 Cities in 2008
4. DaVita Introduces Treatment Evaluator
5. DaVita Honored for 4th Year as Training Top 125 Recipient
6. DaVita Announces Retirement of Former Chief Medical Officer Charles J. McAllister, M.D.
7. NxStage Medical Announces Needle Supply Agreement with DaVita
8. DaVita to Present at UBS Best of Americas Conference
9. Techstreet Launches BuildingBlocks Utility for Industry Standards Saving Time and Increasing Productivity for Engineers
10. Axial Biotech Launches Genetic Test for Adolescent Idiopathic Scoliosis (AIS)
11. Cardinal Health Launches Pyxis(R) MedStation(R) 4000; Introduces Industry-First Service to Interpret Dispensing and Infusion Data
Post Your Comments:
(Date:11/24/2015)... Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT . ... a corporate overview. th Annual Oppenheimer Healthcare Conference ... a.m. PT . Jim Mazzola , vice president of ... --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... 2015  Clintrax Global, Inc., a worldwide provider of clinical research ... announced that the company has set a new quarterly earnings record ... quarter growth posted for Q3 of 2014 to Q3 of 2015. ... Mexico , with the establishment of an Asia-Pacific ... United Kingdom and Mexico ...
(Date:11/24/2015)... New York , November 24, 2015 ... to a recent market research report released by Transparency ... projected to expand at a CAGR of 17.5% during ... "Non-invasive Prenatal Testing Market - Global Industry Analysis, Size, ... estimates the global non-invasive prenatal testing market to reach ...
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading ... culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. ... on the management team and was promoted to Head of InSphero Diagnostics ...
Breaking Biology Technology:
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
(Date:10/29/2015)... 2015 NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... a leading marketplace to discover and buy innovative ... wallet on StackSocial for this holiday season.   ... "Company"), a biometric authentication company focused on the ...
(Date:10/27/2015)... NEW YORK , Oct. 27, 2015 ... the major issues of concern for various industry verticals ... This is due to the growing demand for secure ... practices in various ,sectors, such as hacking of bank ... concerns for electronic equipment such as PC,s, laptops, and ...
Breaking Biology News(10 mins):